[1]李丰, 张园海, 仇慧仙, 等. 静脉注射丙种球蛋白无反应型川崎病的研究进展[J]. 临床儿科杂志, 2013, 31: 283-286. [2]Hara T, Yamamura K, Sakai Y. The up-to-date pathophysiology of Kawasaki disease[J]. Clin Transl Immunology, 2021, 10: e1284.doi:10.1002/cti2.1284. [3]刘丽莎, 朱纯亮, 韩勍, 等. 川崎病急性期患儿血清活化HUVECs NF-κB并促进MMP-9分泌[J]. 基础医学与临床, 2015: 99-100. [4]Chen T, Zhang X, Zhu G, et al. Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-κB and AP-1 signaling pathway in vitro[J]. Medicine (Baltimore), 2020, 99: e22241.doi:10.1097/MD.0000000000022241. [5]Marek-Iannucci S, Ozdemir AB, Moreira D, et al. Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis[J]. JCI Insight, 2021, 6:e151981.doi: 10.1172/jci.insight.151981. [6]Chu S, Shan D, He L, et al. Anemoside B4 attenuates abdominal aortic aneurysm by limiting smooth muscle cell transdifferentiation and its mediated inflammation[J]. Front Immunol, 2024, 15: 1412022.doi: 10.3389/fimmu.2024.1412022. [7]Liu Q, Yang M, Zhang L, et al. Metformin inhibits cholesterol-induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells[J]. Mol Med Rep, 2021, 24:12348.doi: 10.3892/mmr.2021.12348. [8]Zhou Y, Qian C, Tang Y, et al. Advance in the pharmacological effects of quercetin in modulating oxidative stress and inflammation related disorders[J]. Phytother Res, 2023, 37: 4999-5016.doi: 10.1002/ptr.7966. [9]Granieri MC, Rocca C, De Bartolo A, et al. Quercetin and its derivative counteract palmitate-dependent lipotoxi-city by inhibiting oxidative stress and inflammation in cardiomyocytes[J]. Int J Environ Res Public Health, 2023, 20:3492.doi: 10.3390/ijerph20043492. [10]Li J, Li DE, Hu M, et al. Red blood cell distribution width and tumor necrosis factor-α for the early prediction of coronary artery lesion in Kawasaki disease: a retrospective study[J]. Eur J Pediatr, 2022, 181: 903-909.doi: 10.1007/s00431-021-04252-3. [11]Chen J, Liao J, Xiang L, et al. Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review[J]. Front Immunol, 2023, 14: 1237670.doi: 10.3389/fimmu.2023.1237670. [12]Endale M, Park SC, Kim S, et al. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells[J]. Immunobiology, 2013, 218: 1452-1467.doi: 10.1016/j.imbio.2013.04.019. [13]Zhang L, Xu LY, Tang F, et al. New perspectives on the therapeutic potential of quercetin in non-communicable diseases: targeting Nrf2 to counteract oxidative stress and inflammation[J]. J Pharm Anal, 2024, 14: 100930.doi: 10.1016/j.jpha.2023.12.020.
|